Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease
- 28 September 2007
- journal article
- research article
- Published by Elsevier BV in Experimental Neurology
- Vol. 209 (1), 288-291
- https://doi.org/10.1016/j.expneurol.2007.09.012
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal modelsBritish Journal of Pharmacology, 2007
- The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell deathNeurochemistry International, 2007
- Progress report on new antiepileptic drugs: A summary of the Eigth Eilat Conference (EILAT VIII)Epilepsy Research, 2007
- Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemiaBrain Research, 2004
- Current State of Clinical and Morphological Features in Human NCLBrain Pathology, 2004
- Behavioral phenotyping of mice in pharmacological and toxicological researchExperimental and Toxicologic Pathology, 2003
- Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders.Drugs, 2000
- Targeted Disruption of the Cln3 Gene Provides a Mouse Model for Batten DiseaseNeurobiology of Disease, 1999
- Topical Review: The Neuronal Ceroid-LipofuscinosesJournal of Child Neurology, 1995
- Isolation of a novel gene underlying batten disease, CLN3Cell, 1995